Clinical Trial Update: An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial evaluating N-acetylcysteine for cannabis dependence in adolescents; the study has been completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cannabis Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-05-23